Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -43.20% is 43% above its 5-year average of -75.44%, near the high end of its 5-year range (-283.38%–-20.32%).
0.44% below its 12-month average of -43.01%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -40.81%.
OPERATING MARGIN
-43.20%
OPERATING MARGIN AVG TTM
-43.01%
OPERATING MARGIN AVG 3Y
-35.32%
OPERATING MARGIN AVG 5Y
-75.44%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-0.44%
CURRENT VS 3Y AVG
-22.32%
CURRENT VS 5Y AVG
+42.74%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 841 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
RxSight, Inc.
Market Cap
$191.67M
Operating Margin
-43.20%
TTM Avg
-43.01%
3Y Avg
-35.32%
5Y Avg
-75.44%
Market Cap
$188.72M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$183.94M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$200.49M
Operating Margin
-18.58%
TTM Avg
-22.82%
3Y Avg
-47.54%
5Y Avg
-46.03%
Market Cap
$182.11M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$181.63M
Operating Margin
-754.40%
TTM Avg
-377.20%
3Y Avg
-858.29%
5Y Avg
-865.86%
Market Cap
$202.04M
Operating Margin
-1210.58%
TTM Avg
-725.13%
3Y Avg
-451.25%
5Y Avg
-300.83%
Market Cap
$203.40M
Operating Margin
-3099.93%
TTM Avg
-1606.37%
3Y Avg
-882.98%
5Y Avg
-646.62%
Market Cap
$178.36M
Operating Margin
-5219.12%
TTM Avg
-6964.55%
3Y Avg
-7004.82%
5Y Avg
-5165.96%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RxSight, Inc. (RXST) | $191.67M | -43.20% | -43.01% | -35.32% | -75.44% |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $188.72M | 0.00% | 0.00% | 0.00% | 0.00% |
| Canton Strategic Holdings Inc (CNTN)vs › | $183.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| Exagen Inc. (XGN)vs › | $200.49M | -18.58% | -22.82% | -47.54% | -46.03% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.11M | 0.00% | 0.00% | 0.00% | 0.00% |
| Oramed Pharmaceuticals Inc. (ORMP)vs › | $181.63M | -754.40% | -377.20% | -858.29% | -865.86% |
| Surrozen, Inc. (SRZN)vs › | $202.04M | -1210.58% | -725.13% | -451.25% | -300.83% |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $203.40M | -3099.93% | -1606.37% | -882.98% | -646.62% |
| Yarrow Bioscience Inc (YARW)vs › | $178.36M | -5219.12% | -6964.55% | -7004.82% | -5165.96% |
| Alector, Inc. (ALEC)vs › | $205.40M | -692.83% | -418.51% | -274.13% | -339.94% |
Gross Margin
77.5%
Operating Margin
-43.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -40.81% |
| 2026-03-31 | -57.71% |
| 2025-12-31 | -34.77% |
| 2025-09-30 | -40.14% |
| 2025-06-30 | -41.63% |
| 2025-03-31 | -28.17% |
| 2024-12-31 | -21.46% |
| 2024-09-30 | -20.32% |
| 2024-06-30 | -23.89% |
| 2024-03-31 | -36.15% |
| 2023-12-31 | -37.97% |
| 2023-09-30 | -40.80% |
| 2023-06-30 | -65.47% |
| 2023-03-31 | -74.89% |
| 2022-12-31 | -93.18% |
| 2022-09-30 | -126.50% |
| 2022-06-30 | -139.01% |
| 2022-03-31 | -185.39% |
| 2021-12-31 | -174.02% |
| 2021-09-30 | -226.62% |
| 2021-06-30 | -283.38% |
| 2021-03-31 | -319.60% |
| 2020-12-31 | -168.95% |
| 2020-09-30 | -213.57% |
| 2020-06-30 | -325.46% |
| 2020-03-31 | -325.38% |
